Add Yahoo as a preferred source to see more of our stories on Google. A receptionist works at the Otsuka Holdings Co headquarters in Tokyo December 15, 2010. REUTERS/Toru Hanai (Reuters) - Japanese ...

TOKYO (Reuters) - Japan's Otsuka Holdings <4578.T> priced its $2.4 billion initial public offering at the lower end of its range, reflecting worries the drugmaker will struggle to find a successor for ...

Japan-based Otsuka Pharmaceutical has announced that Otsuka BioVentures, LLC (OBV), a corporate venture capital (CVC) firm ...

TOKYO, March 02, 2026--(BUSINESS WIRE)--Otsuka Medical Devices Co., Ltd. (Otsuka Medical Devices) and Otsuka Pharmaceutical Co., Ltd. (Otsuka Pharmaceutical) announce that the Paradise™ Ultrasound ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

TOKYO (Reuters) -Japan's Otsuka Pharmaceutical said on Thursday it agreed to pay more than $1 billion to acquire Jnana Therapeutics as it looks to expand its drug pipeline and research base in the ...

Monday, Esperion Therapeutics (NASDAQ:ESPR) and Otsuka Pharmaceutical Co Ltd announced that the primary endpoint in the Phase 3 trial in Japan for bempedoic acid for hypercholesterolemia was achieved.

Japan's Otsuka Pharmaceuticals accused the U.S. FDA in a unique court suit of manipulating its regulatory procedures to kill off its 7-year exclusivity to market Abilify (aripiprazole) for treating ...